Hypoglycemic Mechanism of Ziya Biti Tablet Based on LC-MS Metabolomics Technique

Cai-juan ZHANG; Xiao-yan JIN; Min-yi QIU; Chi ZHANG; Ling-long LUO; Min WANG; Bao-sheng ZHAO; Xue-yong WANG

doi:10.13422/j.cnki.syfjx.20190604

您当前的位置：

首页 >

文章列表页 >

Hypoglycemic Mechanism of Ziya Biti Tablet Based on LC-MS Metabolomics Technique

Data Mining | 更新时间：2021-02-09

- Hypoglycemic Mechanism of Ziya Biti Tablet Based on LC-MS Metabolomics Technique
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 8, Pages: 141-147(2019)
- 作者机构：
  
  1.北京中医药大学　中药学院，北京　 102488；
  2.北京中医药大学　北京中医药研究院，北京　 100029
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20190604
  CLC： R2-0;R22;R285.5;R289
- Received：02 September 2018，
  
  Published Online：05 December 2018，
  
  Published：20 April 2019
- 稿件说明：
移动端阅览
Cai-juan ZHANG, Xiao-yan JIN, Min-yi QIU, et al. Hypoglycemic Mechanism of Ziya Biti Tablet Based on LC-MS Metabolomics Technique[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 141-147.
DOI：

Cai-juan ZHANG, Xiao-yan JIN, Min-yi QIU, et al. Hypoglycemic Mechanism of Ziya Biti Tablet Based on LC-MS Metabolomics Technique[J]. Chinese journal of experimental traditional medical formulae, 2019, 25(8): 141-147. DOI： 10.13422/j.cnki.syfjx.20190604.

摘要

目的：

观察孜亚比提片对2型糖尿病大鼠的降糖效果，并基于代谢组学技术分析其降糖作用机制。

方法：

根据临床调研结果对不同组分来源的孜亚比提片进行筛选，筛选出最佳组方配比；并以2型糖尿病大鼠为实验对象进行药效学实验研究，正常组和模型组分别给予相同剂量的生理盐水、孜亚比提片组给予300 mg·kg

-1

孜亚比提片、二甲双胍组给予300 mg·kg

-1

盐酸二甲双胍片，每组8只，记录给药后实验组的空腹血糖值及体质量变化并进行数据分析；同时利用超高效液相色谱-线性离子阱/静电场轨道阱组合式高分辨质谱联用(UHPLC-LTQ Orbitrap MS)技术对大鼠血清进行代谢组学分析，采用主成分分析(PCA)，偏最小二乘判别分析(OPLS-DA)对不同组别大鼠血清代谢物进行分析，鉴定出潜在生物标记物，并分析维吾尔族药孜亚比提片的降糖作用机制。

结果：

与正常组比较，模型组大鼠的空腹血糖值升高(

0.01)；与模型组比较，孜亚比提片组大鼠状态整体较好，毛色光滑，其空腹血糖值也有所下降(

0.05)，表明孜亚比提片对2型糖尿病大鼠有一定的降糖作用；根据LC-MS代谢组学数据结果最终得到8个生物标记物。与模型组相比孜亚比提片组中L-valine

propionylcarnitine含量均降低(

0.05)

sphingosine-1-phosphate

LPC(16∶1/0∶0)

LPC(18∶0/0∶0)

LPC(18∶2/0∶0)

LPC(20∶1/0∶0)

PC(19∶0/0∶0)的含量均升高(

0.05)。

结论：

孜亚比提片能够降低2型糖尿病大鼠血糖值，并能改善2型糖尿病大鼠的一般生理特征，其作用机制可能与改善氨基酸代谢，脂质代谢有关。

Abstract

Objective:

To observe the hypoglycemic effect of Uygur medicine Ziya Biti tablet on the type 2 diabetic rats

and analyze the hypoglycemic mechanism based on metabolomic techniques.

Method:

According to the results of clinical research about different origins of Ziya Biti tablet

the optimal composition was screened out; type 2 diabetic rats were taken as an experimental object in the pharmacodynamic experiments; the control group and model group were given the same dose of normal saline

Ziya Biti bablet group was given 300 mg·kg

-1

the metformin group was given 300 mg·kg

-1

metformin hydrochloride. The fasting blood and weight changes of the experimental group after the treatment were recorded and compared with normal group; ultra-high performance liquid chromatography-linear ion trap/electrostatic field orbit trap combined-type high resolution mass spectrometry (UHPLC-LTQ/Orbitrap MS) technology was used to conduct the metabolomics analysis on the rat serum

and principal component analysis (PCA)

partial least squares discriminant analysis (OPLS-DA) on different groups of rat serum metabolites were performed to identify potential biomarkers.

Result:

Compared with the model group

the rats in the Uygur medicine Ziya Biti tablet showed a healthy states

and the blood glucose were decreased(

0.05)

which indicated that Uygur medicine Ziya Biti tablet had a certain hypoglycemic effect on type 2 diabetic rats. Eight biomarkers were finally obtained according to the results. Compared with model group

L-valine and propionylcarnitine in the Uygur medicine group were decreased(

0.05)

while sphingosine-1-phosphate

LPC (16∶1/0∶0)

LPC (18∶0/0∶0)

LPC (18∶2/0∶0)

LPC 20∶1/0∶0)

PC (19∶0/0∶0) were elevated(

0.05).

Conclusion:

The experimental results showed that Uygur medicine Ziya Biti tablet can reduce the blood glucose of type 2 diabetic rats and allivate general physiological characteristics. The mechanism of action may be related to the improvement of amino acid metabolism and lipid metabolism.

关键词

Keywords

references

Stumvoll M B , Goldstein J , van Haeften T W. Type 2 diabetes: principles of pathogenesis and therapy [J]. Lancet , 1900 , 365 ( 9467 ): 1333 - 1346 .

Dedoussis G V , Kaliora A C , Panagiotakos D B. Genes,diet and type 2 diabetes mellitus: a review [J]. Rev Diabet Stud , 2007 , 4 ( 1 ): 13 - 24 .

Yach D , Stuckler D ,and Brownell K D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes [J]. Nat Med , 2006 , 12 ( 1 ): 62 - 66 .

朱禧星．现代糖尿病学 [M]. 上海：上海医科大学出版社， 2000 ： 125 .

李桂荣，李桂红，王烨，等．孜亚比提片对血糖和血脂作用的实验研究 [J]. 中国新药与临床杂志， 2008 , 27 ( 7 ): 495 - 499 .

国家药典委员会．中华人民共和国卫生部药品标准·维吾尔药分册 [M]. 乌鲁木齐：新疆科技卫生出版社， 1999 ： 162 .

Nicholson J K , Lindon J C , Holmes E. Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data [J]. Xenobiotica , 1999 , 29 ( 11 ): 1181 - 1189 .

Kim H K , Choi Y H , Verpoorte R. NMR-based metabolomic analysis of plants [J]. Nat Protoc , 2010 , 5 ( 3 ): 536 - 549 .

Lanza I R , ZHANG S , Ward L E , et al . Quantitative metabolomics by 1H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes [J]. PLoS One , 2010 , 5 ( 5 ): 10538 .

Wishart D S . Quantitative metabolomics using NMR [J]. Trends Anal Chem , 2008 , 27 ( 3 ): 228 - 237 .

Patterson J , Focant J F. Comprehensive two-dimensional gas chromatography time-of-flight mass [J]. J High Resolut Chromatogr , 2003 , 23 ( 3 ): 208 - 214 .

YI L Z , HE J , LIANG Y Z , et al . Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS-LDA [J]. FEBS Lett , 2006 , 580 ( 30 ): 6837 - 6845 .

Fiehn O . Erratum: metabolite profiling for plant functional genomics [J]. Nat Biotechnol , 2000 , 18 ( 11 ): 1157 - 1161 .

Lindon J C , John C , Holmes E , et al . Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project [J]. Toxicol Appl Pharmacol , 2003 , 187 ( 3 ): 137 - 146 .

许国旺，杨军．代谢组学及其研究进展 [J]. 色谱， 2003 , 21 ( 4 ): 316 - 320 .

Stringer K A , Mckay R I , Karnovsky A , et al . Metabolomics and its application to acute lung diseases [J]. Front Immunol , 2016 , 7 ( 4 ): 44 .

Matthiesen R . Bioinformatics methods in clinical research [J]. Methods Mol Biol , 2010 , 646 ( 3 ): 67 - 76 .

王静，袁子民，李云兴，等．基于GC-MS代谢组学法研究黄连、生地黄治疗Ⅱ型糖尿病的配伍机制 [J]. 中国中药杂志， 2014 , 39 ( 3 ): 526 - 530 .

皮子凤，门丽慧，张静，等．五味子治疗大鼠糖尿病肾病作用机制的血清代谢组学研究 [J]. 分析化学， 2015 , 43 ( 2 ): 169 - 175 .

陈瑞，马宁宁，范姗姗，等．基于代谢组学分析金芪降糖片改善2型糖尿病大鼠脂代谢紊乱的作用机制 [J]. 中国实验方剂学杂志， 2018 , 24 ( 20 ): 102 - 107 .

Wishart D S . Metabolomics: the principles and potential applications to transplantation [J]. Am J Transplant , 2010 , 5 ( 12 ): 2814 - 2820 .

James E L , Parkinson E K. Serum metabolomics in animal models and human disease [J]. Curr Opin Clin Nutr Metab Care , 2015 , 18 ( 5 ): 478 - 483 .

陈瑞，马宁宁，范姗姗，等．基于代谢组学分析金芪降糖片改善2型糖尿病大鼠脂代谢紊乱的作用机制 [J]. 中国实验方剂学杂志， 2018 , 24 ( 20 ): 102 - 107 .

常晋霞，刘文虎，王仕宝，等．基于GC-MS代谢组学分析刺五加总苷提取物的降糖作用 [J]. 中国实验方剂学杂志， 2017 , 23 ( 16 ): 101 - 107 .

冯小可，刘佳莅，王岚，等．香砂六君丸对糖尿病胃轻瘫大鼠的血清代谢组学研究 [J]. 中国实验方剂学杂志， 2015 , 21 ( 23 ): 87 - 91 .

XING F . Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway [J]. J Cell Mol Med , 2010 , 13 ( 6 ): 1136 - 1148 .

Murugesan G , Sandhya Rani M R , Gerber C E , et al . Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines [J]. J Mol Cell Cardiol , 2003 , 35 ( 11 ): 1375 - 1384 .

WANG L , LIU J , MO Y Y , et al . Lysophosphatidylcholine-induced surface redistribution regulates signaling of the murine G protein-coupled receptor G2A [J]. Mol Biol Cell , 2005 , 16 ( 5 ): 2234 - 2247 .

Yea K , Kim J , Yoon J H , et al . Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes [J]. J Biol Chem , 2009 , 284 ( 49 ): 33833 - 33840 .

Barber M N , Risis S , YANG C , et al . Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes [J]. PLoS One , 2012 , 7 ( 7 ): 41456 .

王中华．基于代谢组学的2型糖尿病和环境污染物暴露生物标志物研究 [D]．北京：北京协和医学院， 2015 .

宋丹军，潘家琪，李鹏旭，等．溶血磷脂酰胆碱在肝脏疾病中的研究进展 [J]. 中国药理学通报， 2014 , 30 ( 12 ): 1642 - 1646 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research Progress on Signaling Pathways Related to Treatment of Diabetic Cognitive Dysfunction with Traditional Chinese Medicine： A Review

Traditional Chinese Medicine Treatment for Diabetes and Its Complications： A Review

Pathological Mechanism of Diabetes Based on NF-κB Signaling Pathway and Traditional Chinese Medicine Intervention： A Review

Pathogenesis of Diabetes from Theory of Spleen Deficiency Causing Diabetes Based on Intestinal Innate Immunity

Chinese Medicine Intervention in Signaling Pathways Related to Diabetic Ulcer： A Review

Related Author

LI Xinrui

WANG Yuqing

SU Ming

SUN Xinru

ZHANG Hui

XIAO Kangning

LIU Shanxin

ZHANG Xinjun

Related Institution

Shandong Academy of Chinese Medicine

Traditional Chinese Medicine（TCM）;Analysis of Key Disciplines of State Administration of TCM

The First Clinical Medical College，Shandong University of Chinese Medicine

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

College of Chinese Materia Medica， Beijing University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰